i sympathise with the sentiment, but if you look at the track...

i sympathise with the sentiment, but if you look at the track record of the team, and their messaging over the years, a buyout by big pharma is the obvious aim. My interpretation of BOT saying we'll go it alone, taking SB to market, conducting further trials etc is that big pharma has low-balled BOT with current offers. So, BOT calls their bluff, and says we'll go it alone, potentially grow the value, and your next offer will have to be heaps more... They go backwards and forwards trying to balance current and potential value, risks of all sorts etc. to arrive at a price agreeable to both parties. We are in great hands with Vinnie and his team for these type of negotiations. I feel confident they will deliver a good deal for all shareholders. Who knows, we may end up with further trials, but why take the risk, if the price is right after FDA approval? GLTAH